178 related articles for article (PubMed ID: 32778485)
1. Feasibility of volatile organic compound in breath analysis in the follow-up of colorectal cancer: A pilot study.
Steenhuis EGM; Schoenaker IJH; de Groot JWB; Fiebrich HB; de Graaf JC; Brohet RM; van Dijk JD; van Westreenen HL; Siersema PD; de Vos Tot Nederveen Cappel WH
Eur J Surg Oncol; 2020 Nov; 46(11):2068-2073. PubMed ID: 32778485
[TBL] [Abstract][Full Text] [Related]
2. Exhaled-breath Testing for Prostate Cancer Based on Volatile Organic Compound Profiling Using an Electronic Nose Device (Aeonose™): A Preliminary Report.
Waltman CG; Marcelissen TAT; van Roermund JGH
Eur Urol Focus; 2020 Nov; 6(6):1220-1225. PubMed ID: 30482583
[TBL] [Abstract][Full Text] [Related]
3. Prospective Detection of Early Lung Cancer in Patients With COPD in Regular Care by Electronic Nose Analysis of Exhaled Breath.
de Vries R; Farzan N; Fabius T; De Jongh FHC; Jak PMC; Haarman EG; Snoey E; In 't Veen JCCM; Dagelet YWF; Maitland-Van Der Zee AH; Lucas A; Van Den Heuvel MM; Wolf-Lansdorf M; Muller M; Baas P; Sterk PJ
Chest; 2023 Nov; 164(5):1315-1324. PubMed ID: 37209772
[TBL] [Abstract][Full Text] [Related]
4. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
[TBL] [Abstract][Full Text] [Related]
5. Volatile organic compounds in breath can serve as a non-invasive diagnostic biomarker for the detection of advanced adenomas and colorectal cancer.
van Keulen KE; Jansen ME; Schrauwen RWM; Kolkman JJ; Siersema PD
Aliment Pharmacol Ther; 2020 Feb; 51(3):334-346. PubMed ID: 31858615
[TBL] [Abstract][Full Text] [Related]
6. Multi-centre prospective study on diagnosing subtypes of lung cancer by exhaled-breath analysis.
Kort S; Tiggeloven MM; Brusse-Keizer M; Gerritsen JW; Schouwink JH; Citgez E; de Jongh FHC; Samii S; van der Maten J; van den Bogart M; van der Palen J
Lung Cancer; 2018 Nov; 125():223-229. PubMed ID: 30429025
[TBL] [Abstract][Full Text] [Related]
7. Electronic nose technology for detection of invasive pulmonary aspergillosis in prolonged chemotherapy-induced neutropenia: a proof-of-principle study.
de Heer K; van der Schee MP; Zwinderman K; van den Berk IA; Visser CE; van Oers R; Sterk PJ
J Clin Microbiol; 2013 May; 51(5):1490-5. PubMed ID: 23467602
[TBL] [Abstract][Full Text] [Related]
8. Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study.
de Meij TG; Larbi IB; van der Schee MP; Lentferink YE; Paff T; Terhaar Sive Droste JS; Mulder CJ; van Bodegraven AA; de Boer NK
Int J Cancer; 2014 Mar; 134(5):1132-8. PubMed ID: 23959518
[TBL] [Abstract][Full Text] [Related]
9. Feasibility and diagnostic accuracy of an electronic nose in children with asthma and cystic fibrosis.
Bannier MAGE; van de Kant KDG; Jöbsis Q; Dompeling E
J Breath Res; 2019 May; 13(3):036009. PubMed ID: 30213921
[TBL] [Abstract][Full Text] [Related]
10. Breath Analysis Using eNose and Ion Mobility Technology to Diagnose Inflammatory Bowel Disease-A Pilot Study.
Tiele A; Wicaksono A; Kansara J; Arasaradnam RP; Covington JA
Biosensors (Basel); 2019 Apr; 9(2):. PubMed ID: 31013848
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive detection of soft tissue sarcoma using volatile organic compounds in exhaled breath: a pilot study.
Acem I; van Praag VM; Mostert CQ; van der Wal RJ; Neijenhuis RM; Verhoef C; Grünhagen DJ; van de Sande MA
Future Oncol; 2023 Mar; 19(10):697-704. PubMed ID: 37129048
[TBL] [Abstract][Full Text] [Related]
12. Pilot Study: Detection of Gastric Cancer From Exhaled Air Analyzed With an Electronic Nose in Chinese Patients.
Schuermans VNE; Li Z; Jongen ACHM; Wu Z; Shi J; Ji J; Bouvy ND
Surg Innov; 2018 Oct; 25(5):429-434. PubMed ID: 29909757
[TBL] [Abstract][Full Text] [Related]
13. VOC pattern recognition of lung cancer: a comparative evaluation of different dog- and eNose-based strategies using different sampling materials.
Biehl W; Hattesohl A; Jörres RA; Duell T; Althöhn U; Koczulla AR; Schmetzer H
Acta Oncol; 2019 Sep; 58(9):1216-1224. PubMed ID: 31311375
[No Abstract] [Full Text] [Related]
14. Detecting recurrent head and neck cancer using electronic nose technology: A feasibility study.
van de Goor RMGE; Hardy JCA; van Hooren MRA; Kremer B; Kross KW
Head Neck; 2019 Sep; 41(9):2983-2990. PubMed ID: 31012533
[TBL] [Abstract][Full Text] [Related]
15. Differentiating interstitial lung diseases from other respiratory diseases using electronic nose technology.
van der Sar IG; Wijsenbeek MS; Braunstahl GJ; Loekabino JO; Dingemans AC; In 't Veen JCCM; Moor CC
Respir Res; 2023 Nov; 24(1):271. PubMed ID: 37932795
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence.
Deleau C; Buecher B; Rousseau C; Kraeber-Bodéré F; Flamant M; des Varannes SB; Frampas E; Galmiche JP; Matysiak-Budnik T
Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):275-81. PubMed ID: 21304319
[TBL] [Abstract][Full Text] [Related]
17. Expiratory flow rate, breath hold and anatomic dead space influence electronic nose ability to detect lung cancer.
Bikov A; Hernadi M; Korosi BZ; Kunos L; Zsamboki G; Sutto Z; Tarnoki AD; Tarnoki DL; Losonczy G; Horvath I
BMC Pulm Med; 2014 Dec; 14():202. PubMed ID: 25510554
[TBL] [Abstract][Full Text] [Related]
18. Effects of Curative Colorectal Cancer Surgery on Exhaled Volatile Organic Compounds and Potential Implications in Clinical Follow-up.
Altomare DF; Di Lena M; Porcelli F; Travaglio E; Longobardi F; Tutino M; Depalma N; Tedesco G; Sardaro A; Memeo R; de Gennaro G
Ann Surg; 2015 Nov; 262(5):862-6; discussion 866-7. PubMed ID: 26583677
[TBL] [Abstract][Full Text] [Related]
19. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?
Selzner M; Hany TF; Wildbrett P; McCormack L; Kadry Z; Clavien PA
Ann Surg; 2004 Dec; 240(6):1027-34; discussion 1035-6. PubMed ID: 15570208
[TBL] [Abstract][Full Text] [Related]
20. Fecal volatile organic compounds for early detection of colorectal cancer: where are we now?
Bosch S; Berkhout DJ; Ben Larbi I; de Meij TG; de Boer NK
J Cancer Res Clin Oncol; 2019 Jan; 145(1):223-234. PubMed ID: 30554400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
